IVD platforms are evolving rapidly around nucleic acid testing, multiplexed formats, automation and demand for point of care technology. While platform value is often dominated by reagents, a full grasp of system (hardware, software and consumables) architecture and performance is critical to market success.
We fully understand the development process needed to deliver market-leading diagnostic systems.
Our acquisition of Accel Biotech deepens the capability, reach and scale of Ximedica’s comprehensive development offering into key IVD and Life Science growth segments.
We have developed central lab systems, molecular diagnostic platforms, handheld point-of-care devices and various clinical chemistry analyzers. In addition our line of AsysTek™ OEM robotics and accessories enables rapid development of cost competitive automated, high-performance systems.
Our multidisciplinary engineering team provides deep expertise in the core elements found in most laboratory instruments:
- conventional and microfluidics,
- thermal control,
- single-use cartridges
We specialize in IVD systems and related research use only (RUO) life science instruments with expertise in:
- Molecular Diagnostics
- Genomics & Proteomics
- Clinical Chemistry
- Pathology / Tissue Analysis Systems
- DNA Sequencing
- Flow Cytometry
- Microarray Systems
- Microplate/ELISA Readers
- HTS/HCS/Drug Discovery
- Gel Documentation Imagers
- Cell Culture/Incubation
- Chromatography Systems
- Spectroscopy Systems
- Electrophoresis Systems
- Ultrasonic & Magnetics
- Molecular Interaction/Biosensor Systems